Mesa Biotech RSV Test Wins CE Mark

Feb

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Feb

Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Menu

Mesa Biotech RSV Test Wins CE Mark

To read the full story....

Breaking News

In Brief This Week: Yourgene Health, Deep Lens, Canexia Health, and More

DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech

FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Chembio Nabs CE Mark for SARS-CoV-2 Tests, Inks Distribution Agreement with Luas Diagnostics

Progenity Projects 2021 Revenue Growth of Up to 30 Percent

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

What's Popular?

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

FDA Issues Alert About Potential False Negative Test Results From SARS-CoV-2 Mutations

SARS-CoV-2 Mutations Present Unexpected Opportunities, Challenges for MDx Developers

Sponsorships